Highlights
1. SAIA-MH improved functional outcomes by 46 percentage points compared to controls in Mozambican mental health clinics.
2. Medication adherence increased by 18.1 percentage points with the SAIA-MH strategy.
3. The intervention reduced non-adherent days by nearly 12 days per patient visit.
Background
Mental, neurological, and substance use (MNS) disorders represent a significant global health burden, particularly in low- and middle-income countries (LMICs) like Mozambique where treatment gaps exceed 90%. Despite the WHO’s call for task-shifting strategies, implementation science research for optimizing MNS care cascades remains scarce in resource-limited settings.
The Systems Analysis and Improvement Approach for Mental Health (SAIA-MH) adapts a proven HIV care optimization framework to address critical bottlenecks in MNS service delivery. This cluster-randomized trial represents the first rigorous evaluation of an evidence-based implementation strategy specifically designed to improve MNS care cascade outcomes in sub-Saharan Africa.
Study Design
This 3-year trial (NCT05103033) compared an 8-month baseline period with 2-year implementation across 16 government health facilities in Mozambique. Eligible facilities required: MNS service provision including medication management, psychiatric technician and psychologist staff, >100 annual MNS visits, and proximity to urban hubs.
Facilities were randomized 1:1 to SAIA-MH or attentional placebo control using constrained randomization. The SAIA-MH strategy integrated three core components: 1) external facilitation, 2) clinical consultation, and 3) provider team meetings employing systems engineering tools within a continuous quality improvement framework.
Primary outcome combined WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) scores for functional improvement or low impairment. Secondary outcomes included medication adherence and appointment attendance. The study involved 3,837 patients (2,153 intervention, 1,684 control) across 33,055 visits, with primary analysis focusing on 1,751 patients with baseline WHODAS measurements.
Key Findings
The SAIA-MH group demonstrated remarkable improvements across all measured outcomes:
1.
Functional Outcomes
Patients showed 46.0 percentage points (95% CI 34.0 to 58.0; p<0.0001) higher likelihood of functional improvement or low impairment. WHODAS 2.0 scores decreased by 5.9 points more in the intervention group versus controls (95% CI -6.5 to -5.2; p<0.0001).
2.
Medication Adherence
Adherence improved by 18.1 percentage points (15.4 to 20.7; p<0.0001). Non-adherent patient visits had 11.9 fewer non-adherent days (95% CI -17.6 to -6.2; p<0.0001).
3.
Service Utilization
Appointment attendance increased by 18.4 percentage points (15.1 to 21.7; p<0.0001). The intervention showed particular benefit for epilepsy patients (67.3% of cohort), suggesting applicability for high-volume neurological conditions.
Expert Commentary
This trial answers critical questions about implementing complex mental health interventions in resource-constrained settings. Several features deserve emphasis:
1.
Implementation Strategy
SAIA-MH’s success likely stems from its multi-level engagement approach, combining system analysis tools with clinical capacity building. The continuous quality improvement framework allowed local adaptation while maintaining fidelity to core components.
2.
Health System Strengthening
The study demonstrates how task-sharing models can achieve substantial outcomes when paired with structured implementation support. Retention of psychiatric technicians and psychologists throughout the trial period suggests sustainability potential.
3.
Limitations
The absence of ethnicity data and diagnostic heterogeneity (epilepsy predominance) may affect generalizability. Longer-term follow-up is needed to assess durability beyond the implementation period.
Conclusion
SAIA-MH represents a breakthrough implementation strategy for optimizing MNS care cascades in LMICs. The 46-percentage point improvement in functional outcomes exceeds most comparable mental health interventions in high-income settings. These findings strongly support expanded implementation research across diverse diagnostic groups and geographic contexts to address the global mental health treatment gap.
Future research should examine cost-effectiveness, long-term sustainability, and adaptation potential for other chronic disease management in resource-limited settings. The study’s participatory design involving people with lived experience offers a model for equitable global mental health research.
Funding and Registration
This study was funded by the National Institute of Mental Health and registered at ClinicalTrials.gov (NCT05103033).
